| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.038 | 0.6 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.6 |